Pemphigus. S2 Guideline for diagnosis and treatment - guided by
the European Dermatology Forum (EDF) in cooperation with the
European Academy of Dermatology and Venereology (EADV)

J 2015

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

HERTL, M.; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; S. UZUN et al.

Základní údaje

Originální název

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Autoři

HERTL, M.; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; S. UZUN; S. YAYLI; D. MIMOUNI; L. BORRADORI; C. FELICIANI; D. IOANNIDES; P. JOLY; C. KOWALEWSKI; G. ZAMBRUNO; D. ZILLIKENS a M.F. JONKMAN

Vydání

Journal of the European Academy of Dermatology and Venereology, England, Blackwell Publishing, 2015, 0926-9959

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.029

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/15:00083986

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

DOUBLE-BLIND TRIAL; MYCOPHENOLATE-MOFETIL; CLINICAL-TRIAL; SPARING AGENT; PULSE THERAPY; VULGARIS; RITUXIMAB; DEXAMETHASONE; AZATHIOPRINE; PLACEBO

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 24. 9. 2015 16:26, Soňa Böhmová

Anotace

V originále

Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due to its rarity, only few prospective controlled therapeutic trials are available. Objectives:For this reason, a group of European dermatologists with a long-standing interest and expertise in basic and clinical pemphigus research has sought to define diagnostic and therapeutic guidelines for the management of patients with pemphigus. Results:This group identified the statements of major agreement or disagreement regarding the diagnostic and therapeutic management of pemphigus. The revised final version of the pemphigus guideline was finally passed on to the European Dermatology Forum (EDF) for a final consensus with the European Academy of Dermatology and Venereology (EADV) and the European Union of Medical Specialists (UEMS).

Citovat

HERTL, M.; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; S. UZUN; S. YAYLI; D. MIMOUNI; L. BORRADORI; C. FELICIANI; D. IOANNIDES; P. JOLY; C. KOWALEWSKI; G. ZAMBRUNO; D. ZILLIKENS a M.F. JONKMAN. Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology. England: Blackwell Publishing, 2015, roč. 29, č. 3, s. 405-414. ISSN 0926-9959. Dostupné z: https://doi.org/10.1111/jdv.12772.

@article{1312132,
   author = {Hertl, M. and Jedličková, Hana and Karpati, S. and Marinovic, B. and Uzun, S. and Yayli, S. and Mimouni, D. and Borradori, L. and Feliciani, C. and Ioannides, D. and Joly, P. and Kowalewski, C. and Zambruno, G. and Zillikens, D. and Jonkman, M.F.},
   article_location = {England},
   article_number = {3},
   doi = {https://doi.org/10.1111/jdv.12772},
   keywords = {DOUBLE-BLIND TRIAL; MYCOPHENOLATE-MOFETIL; CLINICAL-TRIAL; SPARING AGENT; PULSE THERAPY; VULGARIS; RITUXIMAB; DEXAMETHASONE; AZATHIOPRINE; PLACEBO},
   language = {eng},
   issn = {0926-9959},
   journal = {Journal of the European Academy of Dermatology and Venereology},
   title = {Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)},
   volume = {29},
   year = {2015}
}

TY  - JOUR
ID  - 1312132
AU  - Hertl, M. - Jedličková, Hana - Karpati, S. - Marinovic, B. - Uzun, S. - Yayli, S. - Mimouni, D. - Borradori, L. - Feliciani, C. - Ioannides, D. - Joly, P. - Kowalewski, C. - Zambruno, G. - Zillikens, D. - Jonkman, M.F.
PY  - 2015
TI  - Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
JF  - Journal of the European Academy of Dermatology and Venereology
VL  - 29
IS  - 3
SP  - 405-414
EP  - 405-414
PB  - Blackwell Publishing
SN  - 09269959
KW  - DOUBLE-BLIND TRIAL
KW  - MYCOPHENOLATE-MOFETIL
KW  - CLINICAL-TRIAL
KW  - SPARING AGENT
KW  - PULSE THERAPY
KW  - VULGARIS
KW  - RITUXIMAB
KW  - DEXAMETHASONE
KW  - AZATHIOPRINE
KW  - PLACEBO
N2  - Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due to its rarity, only few prospective controlled therapeutic trials are available. Objectives:For this reason, a group of European dermatologists with a long-standing interest and expertise in basic and clinical pemphigus research has sought to define diagnostic and therapeutic guidelines for the management of patients with pemphigus. Results:This group identified the statements of major agreement or disagreement regarding the diagnostic and therapeutic management of pemphigus. The revised final version of the pemphigus guideline was finally passed on to the European Dermatology Forum (EDF) for a final consensus with the European Academy of Dermatology and Venereology (EADV) and the European Union of Medical Specialists (UEMS).
ER  -

HERTL, M.; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; S. UZUN; S. YAYLI; D. MIMOUNI; L. BORRADORI; C. FELICIANI; D. IOANNIDES; P. JOLY; C. KOWALEWSKI; G. ZAMBRUNO; D. ZILLIKENS a M.F. JONKMAN. Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). \textit{Journal of the European Academy of Dermatology and Venereology}. England: Blackwell Publishing, 2015, roč.~29, č.~3, s.~405-414. ISSN~0926-9959. Dostupné z: https://doi.org/10.1111/jdv.12772.

Přehled o publikaci